Risk factors for clinically significant diffuse parenchymal lung abnormalities persisting after severe COVID-19 pneumonia
CONCLUSIONS: Longer hospital stay was observed to be the only independent predictor of CS-DPLA six months after severe COVID-19. Serum TGF-β should be evaluated further as a biomarker.PMID:37322633 | DOI:10.4103/ijmr.ijmr_2360_22
Source: The Indian Journal of Medical Research - Category: Biomedical Science Authors: Sahajal Dhooria Siddhant Arora Shivani Chaudhary Inderpaul Singh Sehgal Nidhi Prabhakar Nasim Mohammad Riya Sharma Prabir Das Yashwant Kumar Mandeep Garg Goverdhan Dutt Puri Ashish Bhalla Valliappan Muthu Kuruswamy Thurai Prasad Ritesh Agarwal Ashutosh Na Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Coronavirus | COVID-19 | India Health | Pneumonia | Research | Respiratory Medicine | Study